망막 질환 시장(2025년) : 국가별 질환 유병률 데이터

Market Scope's "2025 Retinal Disease Model" delivers deep, country-level insight into the true scale of retinal disease worldwide, with detailed prevalence estimates and five-year forecasts by age group for every country with a population over one million.

Built on the latest clinical research and global demographic projections, this proprietary model provides a rigorous, forward-looking view of retinal disease-and can be customized by geography and disease category to match specific strategic needs. The model enables companies to quantify addressable patient populations, evaluate target markets for clinical- and commercial-stage products, and understand how disease volume and demographics are expected to evolve over time.

Contents:

The "2025 Retinal Disease Model" provides comprehensive, country-level prevalence data by age group across 228 countries with populations over one million, capturing the full global burden of retinal disease. Coverage spans large, commercially significant indications as well as rare inherited conditions, giving a unified view of patient populations relevant to both current markets and future therapeutic development.

Conditions covered include:

• Age-related macular degeneration: early AMD, late AMD, wet AMD, and geographic atrophy
• Diabetic retinal disease: non-proliferative DR (mild, moderate, severe), proliferative DR (with and without DME), diabetic macular edema, and vision-threatening DR
• Retinal vascular disorders: central and branch retinal vein occlusion
• Other retinal conditions: myopic choroidal neovascularization, non-infectious posterior uveitis, retinal detachment, retinal holes, and tears
• Inherited retinal diseases: retinitis pigmentosa, Stargardt disease, choroideremia, Leber congenital amaurosis, Leber hereditary optic neuropathy, achromatopsia, X-linked juvenile retinoschisis, and other IRDs

Methodology:

Market Scope utilizes proprietary demographic models and the latest clinical research to estimate diseased populations at the country level. The retinal disease model integrates data from more than 130 peer-reviewed clinical and epidemiologic studies, with each input carefully evaluated and weighted based on study design, sample size, age stratification, geographic relevance, and scope. These data are then aligned with country-specific population structures and demographic projections to produce consistent, comparable prevalence estimates across markets.